In women with preeclampsia (PE), endothelial cell (EC) dysfunction can lead to altered secretion of paracrine factors that induce peripheral vasoconstriction and proteinuria. This study examined the hypothesis that PE sera may directly or indirectly, through human umbilical vein ECs (HUVECs), stimulate phospholipase C-γ1-1,4,5-trisphosphate (PLC-γ1-IP 3 ) signaling, thereby increasing protein kinase C-α (PKC-α) activity, collagen I expression and intracellular Ca 2+ concentrations ([Ca 2+ ] i ) in human umbilical artery smooth muscle cells (HUASMCs). HUASMCs and HUVECs were cocultured with normal or PE sera before PLC-γ1 silencing. Increased PLC-γ1 and IP 3 receptor (IP 3 R) phosphorylation was observed in cocultured HUASMCs stimulated with PE sera (Po0.05). In addition, PE serum significantly increased HUASMC viability and reduced their apoptosis (Po0.05); these effects were abrogated with PLC-γ1 silencing. Compared with normal sera, PE sera increased [Ca 2+ ] i in cocultured HUASMCs (Po0.05), which was inhibited by PLC-γ1 and IP 3 R silencing. Finally, PE sera-induced PKC-α activity and collagen I expression was inhibited by PLC-γ1 small interfering RNA (siRNA) (Po0.05). These results suggest that vasoactive substances in the PE serum may induce deposition in the extracellular matrix through the activation of PLC-γ1, which may in turn result in thickening and hardening of the placental vascular wall, placental blood supply shortage, fetal hypoxia-ischemia and intrauterine growth retardation or intrauterine fetal death. PE sera increased [Ca 2+ ] i and induced PKC-α activation and collagen I expression in cocultured HUASMCs via the PLC-γ1 pathway.
INTRODUCTION
Preeclampsia (PE), which is characterized by the development of pregnancy-induced hypertension and proteinuria, is a leading cause of maternal and perinatal morbidity and mortality worldwide, as well as preterm birth; 1 its incidence ranges from 2 to 8% of pregnancies. 2 Although some risk factors for the development of PE have been identified and include a history of PE, hypertension, renal disease, obesity and diabetes mellitus, 3 the underlying cause of PE remains unknown.
We previously demonstrated that the abnormal increases in the umbilical arterial resistive and pulsatility indices (RI and PI, respectively) in early-onset severe PE were closely related to the severity of pathologic changes, including placental vascular wall thickening and lumen stenosis, placental infarction and the perinatal mortality rate. 4 Increased expression of collagen I caused by the activation of protein kinase C-α (PKC-α) in the vascular smooth muscle cells (VSMCs) has an important role in the vascular changes associated with PE. 5 Phospholipase C-γ1 (PLC-γ1) is widely expressed in human cells and influences cell proliferation and differentiation. In rat aorta SMCs, the addition of low-density lipoprotein induces extracellular signal-regulated kinase phosphorylation, which is mediated by PLC and PKC. 6 The activation of SMCs PLC-γ1 phosphorylation by growth factors, including vascular endothelial growth factor and platelet-derived growth factor, 7 as well as hypoxia-induced mitogenic factor, 8 results in the hydrolysis of phosphatidylinositol 4,5-bisphosphate. This reaction generates 1,4,5-trisphosphate (IP 3 ) and 1,2-diacylglycerol (DAG), which mediate the release of Ca 2+ and the activation of PKC. Dysregulation of this signaling cascade is a major cause of smooth muscle cell dysfunction; 9 however, the role of PLC-γ1 signaling in PKC-α activation and collagen expression is relatively unknown.
The present study was undertaken to test the hypothesis that PE serum contains soluble placenta-derived factors that may directly or indirectly, through human umbilical vein ECs (HUVECs), activate the PLC-γ1-IP 3 pathway, thereby activating PKC-α, inducing collagen I expression and increasing [Ca 2+ ] i in human umbilical artery smooth muscle cells (HUASMCs). The elucidation of the PLC-γ1-PKC-α pathway role in HUASMCs may help understand the etiology of PE and provide novel therapeutic targets for the prevention and treatment of PE.
MATERIALS AND METHODS

Study protocol
From March 2012 to September 2012, 40 pregnant women undergoing cesarean section in the Affiliated Sixth People's Hospital of Shanghai Jiaotong University (20 patients with PE and 20 age-matched patients with normal full-term pregnancy, similar gestational age, gravidity and parity) were enrolled after informed consent was obtained ( Table 1 ). The patients were diagnosed with PE using welldefined criteria. 10 An additional 50 normal pregnant women undergoing a cesarean section were recruited for the collection of blood samples. Patients with a history of liver, kidney or other cardiovascular diseases were excluded from this study. This study was approved by the institutional review board of the Affiliated Sixth People's Hospital. Signed informed consent was obtained from each participant.
Peripheral blood samples (10 ml) were collected immediately after delivery from 40 pregnant women who underwent cesarean section. Umbilical vein blood samples (50 ml) were also collected from the 50 normal pregnant women who underwent cesarean section. All blood samples were centrifuged, and the supernatant was collected and stored at − 20°C. The umbilical cord was collected from healthy full-term neonates delivered via cesarean section for the establishment of the primary cultures.
Establishment of primary cultures
Primary HUASMC cultures were established according to the tissue block culture method reported in previous studies. 8, 11 HUASMC cultures were confirmed by immunofluorescence analysis of the trophoblast marker α-actin, using an anti-α-actin antibody followed by a PE-labeled secondary antibody (both from Santa Cruz, Dallas, TX, USA). Primary HUVEC cultures were established by the trypsin digestion method. 12 The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum (both from Life Technologies, Carlsbad, CA, USA) and were passaged 3-4 times.
Cells in the logarithmic growth phase were collected and cultured with normal umbilical cord blood serum. After 48 h, the medium was replaced with Dulbecco's modified Eagle's medium that contained 1% normal umbilical vein blood serum for an additional 48 h before the subsequent experiments were performed.
HUASMC and HUVEC coculture
All analyses in the present study were conducted using HUASMC and HUVEC cocultures that were established as described previously. 13 Briefly, 600 μl of HUVECs (5 × 10 5 cells per well) were added to the upper chamber of a Transwell (24 mm Transwell with 0.4 μm Pore Polycarbonate Membrane Insert; Corning, Corning, NY, USA), and 600 μl HUASMCs (5 × 10 5 cells per well) were added to the lower chamber. The cells were cultured in Dulbecco's modified Eagle's medium that contained 20% of neonatal umbilical cord blood serum. The cells were divided into different groups after 24 h, and subsequent experiments were performed. For each independent experiment, each assessment was performed in triplicate.
PLC-γ1 and IP 3 R siRNA transfection PLC-γ1 and IP 3 R siRNA transfection of HUASMCs was conducted as previously described. 14 Briefly, 2 × 10 5 HUASMCs were seeded in sixwell plates in the lower chamber of the Transwell. When the cells grew to 60-70% density, they were transfected with 2 μmol PLC-γ1-siRNA (Cell Signaling, Danvers, MA, USA), IP 3 R-siRNA (Santa Cruz) or the corresponding scrambled-siRNA via Lipofectamine 2000 Transfection Reagent (Life Technologies) and cultured for 24 h. The medium was replaced with Dulbecco's modified Eagle's medium that contained 5% fetal bovine serum, and the silencing efficiency was detected by western blot analysis; the cell viability was detected by MTT (3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide).
Detection of HUASMC viability and apoptosis
The cells were seeded in a 96-well Transwell chamber (HTS Transwell-96 Permeable Support with 0.4 μm Pore Polycarbonate Membrane; Corning). After treatment with medium that contained various concentrations of PE sera (5, 10, 15, 20, 25 and 30% PE sera) over different time points (6, 12, 18, 24, 36, 48 and 72 h), the HUASMC viability was detected by MTT (Sigma, St Louis, MO, USA).
For apoptosis detection, the cells were seeded in 6-well Transwell chambers and treated as previously described. Annexin V-FITC flow cytometry was performed using the Alexa Flour 488 Annexin V/Dead Cell Apoptosis Kit (Life Technologies) to detect HUASMC apoptosis following the manufacturer's instructions.
Western blot analysis
Extraction of HUASMC cytoplasmic and membrane proteins was performed according to a previously published method. 12 The total protein was extracted using CelLytic MT cell lysis buffer (Sigma). After the samples underwent 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, they were transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA) and incubated with the following primary antibodies: PLC-γ1, P-PLC-γ1, IP 3 R and P-IP 3 R (1:1000; all from Cell Signaling, Danvers, MA, USA), PKC-α, (1:200, Life Arterial smooth muscle PLC-γ1 signaling in PE R Jiang et al Technologies), type III procollagen (COL3A1), type I collagen (COL1A) and β-actin (1:1000, all from Santa Cruz). Following incubation at 4°C overnight, the membrane was washed and incubated with Dye 700-fluorescein-conjugated anti-rabbit second antibody (1:4000) or IR Dye 800-fluorescein-conjugated anti-mouse second antibody (1:5000) (both from Bio-Rad) at room temperature for 1 h. After the membranes were washed with Tris-buffered saline with Tween-20, the bands were scanned using an Odyssey Image Scanning System (LI-COR Biosciences, Lincoln, NE, USA). Quantitative analysis of the bands was performed using a Quantity One System (Bio-Rad, Hercules, CA, USA).
Detection of membrane PKC activity
Analysis of membrane PKC activity was performed using a PKC Assay Kit (Life Technologies), which measures the phosphorylation of a synthetic peptide from myelin basic protein, as previously described. 15 Briefly, the protein extracts were incubated for 20 min at room temperature with a PKC activation preparation or a pseudosubstrate inhibitor peptide, and the incorporation of [γ-32 P]ATP into myelin basic protein was measured. The activity was calculated as the total picomoles PKC per min and normalized for cell number.
Measurement of [Ca 2+ ] i concentrations
[Ca 2+ ] i was analyzed in HUASMCs as previously described 16 using Fluo-3/AM (Sigma). Briefly, the cells were seeded on coverslips and treated with calcium-free medium that contained PE serum for 2 h after the cells grew to 75% density. After Fluo-3/AM (5 μM) was added to the calcium-free medium, the cells were incubated at 37°C for 30 min in the dark. The cells were washed two times with physiologic extracellular fluid (141 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 10 mM glucose, 10 mM HEPES, pH 7.4), and 20 cells were selected from each group. A laser confocal microscope (MRC-1024; Bio-Rad, Hercules, CA, USA) was used to observe the fluorescence intensity. Each cell was scanned once every 2 s, and 15 scans were performed.
Statistical analysis
The continuous data are presented as the mean ± standard deviations, and the categorical data are summarized as numbers and percentages.
The comparisons in the baseline characteristics between the subjects with normal pregnancy (N) and the subjects with PE were performed using an independent t-test for continuous data and a Fisher's exact test for categorical data. The effects of different PE serum concentrations or different time points on cell viability were evaluated using one-way analysis of variance. Pairwise post hoc tests using Bonferroni correction were applied when significant findings were identified by analysis of variance. The comparisons in cell viability, apoptosis rate, relative protein expression and fluorescence intensity were performed using an independent t-test between two independent groups (N vs PE; N vs PE+PLC-γ1 siRNA) and using a paired t-test between two dependent groups (PE vs PE+PLC-γ1 siRNA; PE vs PE+IP 3 R siRNA).
Bonferroni corrections were applied to control the overall type I error when conducting multiple comparisons. The statistical analyses were performed with SAS software version 9.2 (SAS Institute, Cary, NC, USA). A two-tailed Po0.05 indicated statistical significance.
RESULTS
Effects of PE serum on the viability of cocultured HUASMCs
In our previous study, PE serum enhanced the proliferation and reduced the apoptosis of HUASMCs in the presence and absence, respectively, of cocultured HUVECs. 10 Because cocultures of HUVECs and HUASMCs mimic the pathogenesis of placental artery abnormalities in PE, we performed all experiments in the present study using cocultures. The cocultured HUASMCs were treated with medium that contained various concentrations of PE sera for 24 h. The cell viability in the PE group was significantly higher compared with the normal group (N) at the PE serum concentrations of 10-25% (Po0.001); the optimal cell viability was obtained with medium that contained 10% PE serum (Po0.001 compared with other concentrations with the exception of 15%; Figure 1a ). Therefore, this concentration of sera was selected for subsequent experiments. The cocultured cells were then cultured with 10% PE serum for various time points. As shown in Figure 1b , cell viability in the PE group was significantly higher compared with the N group at 12-48 h (Po0.001), and the cell viability was greatest at 24 h (Po0.001 compared with the other time points). Therefore, the cells were cocultured in 10% PE serum for 24 h in subsequent experiments.
Effects of PLC-γ1 siRNA on cocultured HUASMC viability The silencing effects of PLC-γ1 siRNA and IP 3 R siRNA in HUASMCs were subsequently determined. As shown in Figures 2a and c , PLC-γ1 and IP 3 R were significantly decreased in the PLC-γ1-siRNA and IP 3 R groups, respectively (Po0.05). However, as shown in Figures 2b and d , the cell viability did not change (P40.05).
PE serum activated the PLC-γ1-IP 3 R pathway in cocultured HUASMCs As shown in Figure 3a , the PE group had significantly higher relative p-PLC-γ1 levels compared with the other three groups (Po0.001); the PLC-γ1 expression was significantly decreased in the N+PLC-γ1-siRNA group compared with the N group and was significantly decreased in the PE+PLC-γ1-siRNA group compared with the PE group (Po0.001). The p-IP 3 R levels were consistently and significantly higher in the PE group compared with the N, N+PLC-γ1-siRNA and PE+PLCγ1-siRNA groups (Figure 3b ; Po0.001). No difference was identified in the relative protein expression of IP 3 R among the four treatment groups (Figure 3b ; P40.05).
PE serum increased the proliferation of cocultured HUASMCs and reduced their apoptosis
The HUASMC viability and apoptosis were determined after treatment with normal serum (N), normal serum in addition to PLC-γ1 siRNA, PE serum and PE serum in addition to PLC-γ1 siRNA. The cells treated with PE had significantly higher viability (Figure 4a ; Po0.001) and lower apoptosis (Figure 4b ; Po0.001) compared with the cells cultured with normal serum. Moreover, the effects of PE serum on HUASMC viability and apoptosis were abrogated with PLC-γ1 siRNA (Figure 4 ; Po0.001). Effects of PE serum and PLC-γ1 siRNA on PKC-α activity and collagen I expression by cocultured HUASMCs Cytosolic PKC-α (c-PKC-α) activity was significantly lower in the PE group compared with the N group (Po0.001), which was abrogated with PLC-γ1 silencing (Figure 6a ; Po0.001). However, membrane PKC-α expression was significantly higher in the PE group compared with the N group (Figure 6a ; Po0.001). Again, no differences were observed between the PE+PLC-γ1 siRNA and N groups (P40.05). As shown in Figure 6b , PKC-α activity was significantly higher in the PE group compared with the N group (Po0.001).
Although the PE+PLC-γ1 siRNA group had significantly lower PKC-α activity compared with the PE group (Po0.001), it remained significantly higher compared with the N group (P = 0.009). Because PKC-α-induced collagen I expression in VSMCs has an important role in the vascular changes associated with PE, 5 we subsequently analyzed the effects of PE sera on collagen I expression by cocultured HUASMCs. The analysis of relative type I collagen expression revealed a significant increase in the PE group (Figure 6c ; Po0.001), which was inhibited by PLC-γ1 siRNA (Po0.001) but not IP 3 R siRNA. No difference in the relative expression of type III procollagen was observed among the three treatment groups (Figure 6c ; P40.05).
DISCUSSION
Altered EC secretion of factors into the serum in PE patients can induce peripheral vasoconstriction and proteinuria. 5 This study analyzed the effects of PE sera on PLC-γ1-PI3 signaling, PKC-α activity, collagen I expression and [Ca 2+ ] i in HUASMCs cocultured with HUVECs. PLC-γ1 siRNA could reverse the PKC-α activation and collagen I expression induced by PE serum. These results suggest that vasoactive substances in the PE serum may induce deposition in the extracellular matrix (ECM) through the activation of PLC-γ1, which may in turn result in thickening and hardening of the placental vascular wall, placental blood supply shortage, fetal hypoxia-ischemia and intrauterine growth retardation or intrauterine fetal death.
Both VSMCs and ECs have key roles in the pathogenesis of hypertensive vascular diseases, including PE. Following vascular EC death or injury, inotropic agents, including angiotensin-II (Ang-II) 17 and endothelin-1 (ET-1), 18 may be released, which may induce spasmodic contraction and/or migration of VSMCs. Subsequent extensive ECM remodeling results in the vascular intima thickening and stenosis characteristic of vascular disease, which may shrink the arterial wall 19 and increase peripheral resistance and fetal blood pressure. 20 Specifically, increased type I collagen synthesis has been identified in pulmonary hypertension vascular remodeling, 21 as well as in sympathetic ventricular wall remodeling. 22 Furthermore, in PE patients, subintimal migration of umbilical cord VSMCs that synthesize a large amount of ECM (primarily type I collagen) is closely associated with the thickening and stenosis of the vascular wall. 23 Collagen accumulation may also result from suppressed collagen degradation 20 because reduced matrix metalloproteinase-2 and matrix metalloproteinase-9 were observed in an in vivo model of reduced uteroplacental perfusion pressure. 24 In the present study, PE sera increased cocultured HUASMC proliferation and collagen I expression, which is consistent with previous reports 5, 25, 26 that have described a role for the PKC-nuclear factor-κB signaling pathway in this process. The increased collagen I expression by PE sera was abrogated by PLC-γ1 siRNA, but not IP 3 R siRNA, which suggests that PKC activity may be required for collagen I expression. Because Ang-II-mediated expression of p21-activated kinase 1 in VSMCs was dependent on both intracellular Ca 2+ mobilization and PKCδ, 27 further studies will assess the role of nuclear factor-κB-mediated gene expression, as well as PKCδ in this process.
Increased type III collagen has been observed in PE umbilical cord veins. 20 In addition, the culture of adventitial fibroblasts with conditioned media from tumor growth factor-β-treated SMCs induced collagen-3 but not collagen-1 expression. 28 Therefore, we analyzed the effects of PE sera on precollagen III synthesis by cocultured HUASMCs and observed no difference compared with normal sera. Further studies will determine if the PE sera contains factors that directly or indirectly influence collagen synthesis or degradation in PE, including matrix metalloproteinases, platelet-derived growth factor, tumor growth factor-β and tumor necrosis factor-α (TNF-α). 26 The role of the tumor growth factor-β/Smad3 pathway will also be explored in detail. 29 Because of the role of apoptosis in the placenta in normal pregnancy, 30 we also analyzed the effects of PE sera on apoptosis in cocultured HUASMCs. PE sera reduced HUASMC apoptosis, which was inhibited by PLC-γ1 siRNA. This effect is different from the apoptosis-inducing activity reported for PKCδ in PE placentas, which induces Bax dissociation from 14-3-3ξ. 31 In the present study, PE sera-induced PKC-α activation was inhibited with PLC-γ1 siRNA. Snetkov et al. 32 described a role for PLC in the mediation of PKC activation in VSMCs, thereby having an important role in activator-induced vascular contraction, as well as the synthesis and deposition of ECM. Moreover, VSMC activators, such as Ang-II and ET-1, can activate PLC, 12 and the subsequent hydrolysis of phosphatidylinositol 4,5-bisphosphate yields IP 3 and DAG. IP 3 may induce cell contraction via an increase in [Ca 2+ ] i as the binding of Ca 2+ to calmodulin activates myosin light-chain kinase, which leads to the phosphorylation of myosin light chain and the subsequent activation of myosin ATPase. 33 In addition, increased DAG may result in persistent PKC activation and therefore continuous SMC contraction, as well as mitogenactivated protein kinase kinase activation via Raf-1 and mitogen-activated protein kinase, which may increase ECM synthesis in VSMCs. 9 Thus, the PLC-phosphatidylinositol 4,5-bisphosphate-IP 3 and DAG signaling pathways can not only induce SMC contraction via PKC activation but also ECM synthesis. Given the role of altered calcium signaling and the loss of nitric oxide synthesis by VSMCs in PE 34, 35 and the potential role of calcium nutritional deficiency in PE, 36, 37 the effects of PE sera on calcium homeostasis were analyzed. PE sera increased [Ca 2+ ] i , which was mediated by the PLC-γ1-PKC-α pathway. These results are consistent with Krupp et al., 38 who reported an increased [Ca 2+ ] i in response to arachidonic acid by PE HUASMCs. Moreover, calcium pretreatment inhibited EC activation by necrotic trophoblastic debris, as well as PE sera, and these protective effects were inhibited by a nitric oxide synthase inhibitor. 39 Further studies will assess the effects of PLC-γ1-PKC-α pathway inhibition on calcium homeostasis in PE.
PE sera increased the [Ca 2+ ] i in cocultured HUASMCs and peaked at 2 h (data not shown). This delayed response may, at least in part, be because of the transwell coculture system that has been used. Because Green et al. 40 reported that PE serum did not increase Ca 2+ levels in HUASMCs cultured alone, we anticipate that HUVEC coculture is necessary to observe PE sera-induced increases in [Ca 2+ ] i .
Although the present study did not determine the molecule in the PE sera that induced the responses in HUASMCs either directly or indirectly via HUVECs, Steinert et al. 37 suggested that a monooxygenase metabolite may be responsible for the increased [Ca 2+ ] i observed in PE HUASMCs. Moreover, the presence of inotropic vasoactive substances, including Ang-II and ET-1, in the serum of PE patients has been detected; [41] [42] [43] [44] however, it is not clear whether these substances are derived from the placenta or injured vascular ECs. ET-1 can regulate smooth muscle cell proliferation 45 and induce endoplasmic reticulum stress via the PLC-IP 3 pathway in PE; 46 however, ET-1 or Ang-II alone fails to explain the pathogenesis of vascular disease in PE patients. In addition, whether the vasoactive substances in the serum of PE patients exert their effects via the induction of VSMC contraction and ECM synthesis in a PLC-phosphatidylinositol 4,5-bisphosphate-IP 3 -and DAG-dependent manner remains unclear. Given the effects of PE sera on the induction of type I collagen expression via PKC-nuclear factor-κB signaling, 5, 24 additional paracrine mediators may be responsible for the activation of the cis-and Arterial smooth muscle PLC-γ1 signaling in PE R Jiang et al trans-acting factors responsible for increased type I collagen expression in PE. Increased thrombin, basic fibroblast growth factor and TNF-α levels have also been reported in PE and may induce smooth muscle cell proliferation. 47, 48 Thus, further studies will be conducted to identify the factor(s) responsible for the effects of PE sera on HUASMCs proliferation, ECM expression and function.
PE serum contains many ligands that can potentially activate other PLC isozymes to generate IP 3 in HUASMCs. Although PLC-γ1 knockdown reduced IP 3 R levels to that of the normal group, which suggests that it is the major form in these cells, other PLC isozymes may still be present. Thus, further studies will assess the PLC isozyme expression profiles in our HUASMC primary cultures.
In conclusion, vasoactive substances in PE serum may induce the deposition of the ECM through the activation of PLC-γ1, which thereby results in the vascular dysfunction associated with PE. The elucidation of the role of the PLC-γ1-PKC-α pathway in HUASMCs may help understand the etiology of PE and provide new therapeutic targets for the prevention and treatment of PE. 
